Medicine

Classifying PML risk with disease modifying therapies.

J. Berger

2017.2.1Multiple Sclerosis and Related Disorders

DOI: 10.1016/j.msard.2017.01.006

tlooto Summary

A logical classification for stratifying DMT PML risk is important for both the physician and patient in contextualizing risk/benefit ratios asAdditional experience accumulates regarding PML and the DMTs, this early effort will undoubtedly require revisiting.

Abstract

Abstract is not available.

Citation format

BERGER, J. Classifying PML risk with disease modifying therapies. Multiple Sclerosis and Related Disorders, 2017, 12: 59–63.